Clinton Foundation partner raking in millions from EpiPen price-gouging

In 2007, pharmaceutical company Mylan purchased the rights to the brand name device EpiPen, which is used to inject epinephrine in the case of a life-threatening anaphylactic allergic reaction. At that time, the devices cost $57 each. The price has since risen steadily to $609.

Roughly 43 million people in the United States are at risk of anaphylactic reactions, and the high price of EpiPens is placing life-saving medication beyond their reach.

On August 24, presidential candidate Hillary Clinton called Mylan’s pricing “outrageous,” saying, “It’s just the latest troubling example of a company taking advantage of its consumers.”

What Clinton did not mention is that Mylan has a history of donating to the Clinton Foundation.


Categories: Economy, Politics